Accu-Chek® Insight insulin pumps – some need to be fitted with key frames to reduce the risk of accidentally unlocking keys or pressing the bolus buttons
Manufactured by Roche Diabetes Care – Important instructions on how to fit 2 separate key frames to prevent accidentally activating the pump (MDA/2019/009).
Actions
- Identify affected patients and pumps (serial numbers below 32100000)
- Ensure that all patients and carers:
- receive a copy of manufacturer’s Field Safety Notice (FSN) and instructions for use dated December 2018
- understand the information detailed in the FSN
- apply the new key frames as instructed by the manufacturer
- Return the FSN acknowledgment form to Roche as currently they have not received enough responses
This Medical Device Alert is to ensure that all relevant organisations are aware of this FSN and encourage their patients to apply the key frames.
Action by
- All healthcare workers responsible for patients who use these devices.
- Diabetes departments.
Deadlines for actions
Actions underway: 12 March 2019
Actions complete: 02 April 2019
Medical Device Safety Officers (in England): ask the manufacturer to add you to their distribution list for field safety notices (FSNs). This is to help with reconciliation.
Remember : if your organisation receives an FSN from a manufacturer, always act on it. Do not wait for a communication from MHRA.
Problem / background
The key lock function of the pump locks only the buttons on the front of the insulin pump. It does not lock the quick bolus keys on the top of the pump.
The manufacturer has received reports of unintended boluses being delivered. Revised handling instructions were published in 2016 (MHRA issued MDA/2016/016) and now Roche Diabetes Care is providing users with key frames to fit onto all affected Accu-Check Insight pumps (i.e. pumps with serial numbers below 32100000) to further reduce the risk of accidental bolus delivery.
Manufacturer contacts
Roche Diabetes Care
Tel: 0800 731 2291
Manufacturer FSCA Reference: SB_RDC_2015_05_2
Distribution
If you are responsible for cascading these alerts in your organisation, these are our suggested distribution lists.
Trusts (NHS boards in Scotland)
CAS and NICAS liaison officers for onward distribution to all relevant staff including:
- Community diabetes specialist nurses
- Community hospitals
- Diabetes clinics/outpatients
- Diabetes nurse specialists
- Diabetes, directors of
- EBME departments
- Outpatient clinics
- Paediatric diabetic nurse specialists
- Paediatric wards
- Paediatricians
- Paediatrics departments
- Pharmacists
- Risk managers
- Supplies managers
NHS England area teams
CAS liaison officers for onward distribution to all relevant staff including:
- General practitioners (for information only)
This Medical Device Alert is being sent to GPs for information only, in circumstances where patients may seek advice about the contents of this notice. GPs need take no further action on receipt of this alert.
Independent distribution
Establishments registered with the Care Quality Commission (CQC) (England only)
- Clinics
- Hospices
- Hospitals in the independent sector
- Independent treatment centres
- Private medical practitioners
Please note: CQC and OFSTED do not distribute these alerts. Independent healthcare providers and social care providers can sign up to receive MDAs directly from the Central Alerting System (CAS) by sending an email to: [email protected] and requesting this facility.
Enquiries
England
Send enquiries about this notice to MHRA, quoting reference number MDA/2019/009 or 2018/011/028/701/019.
Technical aspects
Enitan Taiwo or Natasha Mthethwa, MHRA
Tel 020 3080 7122/ 7086
[email protected] or [email protected]
Clinical aspects
Devices Clinical Team, MHRA
Tel: 020 3080 7274
To report an adverse incident involving a medical device in England use the Yellow Card reporting page
Northern Ireland
Northern Ireland Adverse Incident Centre (NIAIC), CMO Group, Department of Health, Social Services and Public Safety
Tel: 0208 9052 3868
To report an adverse incident involving a medical device in Northern Ireland use the forms on the website.
Alerts in Northern Ireland are distributed via the NICAS system.
Scotland
Incident Reporting and Investigation Centre (IRIC), Health Facilities Scotland, NHS National Services Scotland
Tel: 0131 275 7575
To report an adverse incident involving a medical device in Scotland, email IRIC to request a webform account.
For more information, or if you can’t access the webform, visit the website: how to report an adverse incident
Wales
Population Healthcare Division, Welsh Government
Tel: 03000 250986 / 03000 255510
To report an adverse incident involving a medical device in Wales, use the Yellow Card reporting page and follow specific advice for reporting in Wales in MDA/2004/054 (Wales).
MHRA is a centre of the Medicines and Healthcare products Regulatory Agency, an executive agency of the Department of Health and Social Care.
Download document